1 Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
3 Department of Oncology, First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
4 Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
5 Beijing Engineering Research Center for Precision Medicine and Transformation of Hepatitis and Liver Cancer, Beijing, 100069, China.
6 Department of Critical Care Medicine, Jiangxi Cancer Hospital, Jiangxi Cancer Center, Nanchang, 330029, China.
7 Department of Lymphohematology, Jiangxi Cancer Hospital, Jiangxi Cancer Center, Nanchang, 330029, China.
8 Department of Biochemistry & Molecular Biology and Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA, 70112, USA.
9 Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China. haoqian@fudan.edu.cn.
10 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. haoqian@fudan.edu.cn.
11 Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China. xiangzhou@fudan.edu.cn.
12 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. xiangzhou@fudan.edu.cn.
13 Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China. xiangzhou@fudan.edu.cn.
14 Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism (Ministry of Science and Technology), Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China. xiangzhou@fudan.edu.cn.